Despite multiple disparate prognostic risk analysis systems for evaluating clinical outcome for patients with myelodysplastic syndrome (MDS), imprecision persists with such analyses. To attempt to improve on these systems, an International MDS Risk Analysis Workshop combined cytogenetic, morphologic...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!